HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
Source: CNBC· Annika Kim Constantino· August 25, 2026
SynaBot summary
The Department of Health and Human Services is establishing two new deputy commissioner positions at the FDA. One role will specifically address technology's impact and integration within the agency's operations and regulatory processes.
Key takeaways
- FDA creating new deputy commissioner for technology
- Focus on technology's role in drug regulation
- Signals increased agency tech adoption
- Potential impact on AI in healthcare
Why it matters
This FDA restructuring signals a stronger focus on integrating advanced technologies into drug development and regulatory oversight. Professionals using AI for research or compliance should anticipate more tech-centric guidance and potentially faster approval pathways.
This story was reported by CNBC. Read the full original article:
Read on CNBC 
